date,title,source
Oct-19-18,"Report: Developing Opportunities within Just Energy Group, Tetra Technologies, Domtar, MacroGenics, ObsEva SA, and Magic Software Enterprises  Future Expectations, Projections Moving into 2018",GlobeNewswire
Oct-31-18,"ObsEva SA to Hold Third Quarter 2018 Financial Results and Business Update Call on November 8, 2018",GlobeNewswire
Nov-06-18,ObsEva Sees Hammer Chart Pattern: Time to Buy?,Zacks
Nov-07-18,ObsEva SA to Participate in November Investor Conferences,GlobeNewswire
Nov-08-18,"ObsEva SA (OBSV) Reports Q3 Loss, Misses Revenue Estimates",Zacks
Nov-08-18,ObsEva Reports Third Quarter 2018 Financial Results and Provides Business Update,GlobeNewswire
Nov-19-18,Edited Transcript of OBSV.O earnings conference call or presentation 8-Nov-18 1:00pm GMT,Thomson Reuters StreetEvents
Nov-20-18,Edited Transcript of OBSV.O earnings conference call or presentation 8-Nov-18 1:00pm GMT,Thomson Reuters StreetEvents
Nov-28-18,"ObsEva SA Announces Initiation of Phase 3 IMPLANT 4 Trial of Nolasiban in Europe, Canada and Russia for Improving IVF Outcomes",GlobeNewswire
Nov-29-18,"ObsEva SA to Host R&D Investor Day December 7, 2018",GlobeNewswire
Dec-06-18,"ObsEva SA to Participate in BMO Healthcare Conference December 12, 2018",GlobeNewswire
Dec-07-18,ObsEva R&D Day Showcases Multiple Womens Health Programs and Outlines Plans for Transition to Commercial Operations,GlobeNewswire
Dec-11-18,What Kind Of Investor Owns Most Of ObsEva SA (NASDAQ:OBSV)?,Simply Wall St.
Dec-21-18,ObsEva SA Announces Completion of Patient Recruitment in PRIMROSE 2 Phase 3 Clinical Trial of Linzagolix for the Treatment of Heavy Menstrual Bleeding Associated with Uterine Fibroids,GlobeNewswire
Jan-02-19,"ObsEva SA to Participate in JP Morgan Healthcare Conference January 7-10, 2019",GlobeNewswire
Jan-23-19,ObsEva SA Reports Initial Good Safety of OBE022 in Pregnant Women with Preterm Labour and Announces Start of Part B of the PROLONG Trial,GlobeNewswire
Feb-22-19,ObsEva SA to Participate in Upcoming Investor Conferences,GlobeNewswire
Feb-25-19,Are ObsEva SAs (NASDAQ:OBSV) Interest Costs Too High?,Simply Wall St.
Feb-27-19,"ObsEva SA to Hold Fourth Quarter and Full Year 2018 Financial Results and Business Update Call on March 5, 2019",GlobeNewswire
Mar-05-19,Edited Transcript of OBSV.O earnings conference call or presentation 5-Mar-19 1:00pm GMT,Thomson Reuters StreetEvents
Mar-05-19,ObsEva SA (OBSV) Q4 2018 Earnings Conference Call Transcript,Motley Fool
Mar-05-19,"ObsEva Reports Fourth Quarter and Full Year 2018 Financial Results, Provides Business Update",GlobeNewswire
Mar-13-19,"ObsEva SA to Present OBE022 Clinical Data for Treatment of Pre-term labor (PTL) at the SRI 66th Annual Scientific Meeting, March 12 -16, 2019",GlobeNewswire
Mar-25-19,Edited Transcript of OBSV.O earnings conference call or presentation 5-Mar-19 1:00pm GMT,Thomson Reuters StreetEvents
Mar-29-19,Publication of ObsEva SA Invitation to 2019 Annual General Meeting of Shareholders,GlobeNewswire
Apr-01-19,ObsEva SA to Participate in Upcoming Investor Conferences,GlobeNewswire
Apr-29-19,ObsEva SA Reports Further Infant Follow-up Data from IMPLANT2 Trial Echoing Favorable Safety Profile of Nolasiban in IVF,GlobeNewswire
May-01-19,"ObsEva SA to Hold First Quarter 2019 Financial Results and Business Update Call on May 9, 2019",GlobeNewswire
May-03-19,"The Daily Biotech Pulse: Obseva Reports Positive Endometriosis Drug Trial, Assembly Biosciences Execs Depart, Coherus Settles With Amgen",Benzinga
May-03-19,ObsEva SA Reports Consistent Long-Term Findings from Phase 2b EDELWEISS trial of Linzagolix for Endometriosis-Associated Pain,GlobeNewswire
May-08-19,"ObsEva SA Announces that ObsEvas Shareholders Approved all Board Proposals at its 2019 Annual General Meeting held on May 8, 2019",GlobeNewswire
May-09-19,Heres What Hedge Funds Think About ObsEva SA (OBSV),Insider Monkey
May-09-19,"ObsEva SA (OBSV) Reports Q1 Loss, Lags Revenue Estimates",Zacks
May-09-19,ObsEva Reports First Quarter 2019 Financial Results,GlobeNewswire
May-09-19,"ObsEva SA Announces Initiation of Phase 3 EDELWEISS 2 and 3 Trials of Linzagolix for Endometriosis Associated Pain in U.S., Canada and Europe",GlobeNewswire
May-10-19,Edited Transcript of OBSV.O earnings conference call or presentation 9-May-19 12:00pm GMT,Thomson Reuters StreetEvents
May-16-19,ObsEva SA to Participate in Upcoming Investor Conferences,GlobeNewswire
May-31-19,Does The ObsEva SA (NASDAQ:OBSV) Share Price Fall With The Market?,Simply Wall St.
Jun-04-19,ObsEva SA Announces Completion of Patient Recruitment in IMPLANT 4 Phase 3 Clinical Trial of Nolasiban for Improving IVF Outcomes,GlobeNewswire
Jun-07-19,Edited Transcript of OBSV.O earnings conference call or presentation 9-May-19 12:00pm GMT,Thomson Reuters StreetEvents
